BrainInsight

Hyperfine, Inc. · K223268 · 2022-12-16

BrainInsight is an AI-enabled medical device from Hyperfine, Inc., listed by FDA (510(k), K223268) with a decision date of 2022-12-16. Review panel: Radiology.

FDA submission numberK223268
Pathway510(k)
CompanyHyperfine, Inc.
Review panel (specialty)Radiology
FDA decision date2022-12-16
DecisionSubstantially Equivalent
Product codeQIH
ClassificationAutomated Radiological Image Processing Software
Device class2
Regulation number892.2050
Review time (calendar days)53
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from Hyperfine, Inc. · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.